These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
343 related articles for article (PubMed ID: 34291337)
1. Hypoxia and glucose metabolism assessed by FMISO and FDG PET for predicting IDH1 mutation and 1p/19q codeletion status in newly diagnosed malignant gliomas. Suzuki K; Kawai N; Ogawa T; Miyake K; Shinomiya A; Yamamoto Y; Nishiyama Y; Tamiya T EJNMMI Res; 2021 Jul; 11(1):67. PubMed ID: 34291337 [TBL] [Abstract][Full Text] [Related]
2. Static Song S; Wang L; Yang H; Shan Y; Cheng Y; Xu L; Dong C; Zhao G; Lu J Eur Radiol; 2021 Jun; 31(6):4087-4096. PubMed ID: 33211141 [TBL] [Abstract][Full Text] [Related]
3. The Diagnostic Value of Conventional MRI and CT Features in the Identification of the IDH1-Mutant and 1p/19q Co-Deletion in WHO Grade II Gliomas. Zhao K; Sun G; Wang Q; Xue Z; Liu G; Xia Y; Yao A; Zhao Y; You N; Yang C; Xu B Acad Radiol; 2021 Jul; 28(7):e189-e198. PubMed ID: 32359929 [TBL] [Abstract][Full Text] [Related]
4. RNA editing-based classification of diffuse gliomas: predicting isocitrate dehydrogenase mutation and chromosome 1p/19q codeletion. Chen SC; Lo CM; Wang SH; Su EC BMC Bioinformatics; 2019 Dec; 20(Suppl 19):659. PubMed ID: 31870275 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of PET/CT with Ogawa T; Kawai N; Miyake K; Shinomiya A; Yamamoto Y; Nishiyama Y; Tamiya T EJNMMI Res; 2020 May; 10(1):44. PubMed ID: 32382870 [TBL] [Abstract][Full Text] [Related]
6. Usefulness of positron emission tomography for differentiating gliomas according to the 2016 World Health Organization classification of tumors of the central nervous system. Takei H; Shinoda J; Ikuta S; Maruyama T; Muragaki Y; Kawasaki T; Ikegame Y; Okada M; Ito T; Asano Y; Yokoyama K; Nakayama N; Yano H; Iwama T J Neurosurg; 2020 Oct; 133(4):1010-1019. PubMed ID: 31419796 [TBL] [Abstract][Full Text] [Related]
7. MRI Scoring Systems for Predicting Isocitrate Dehydrogenase Mutation and Chromosome 1p/19q Codeletion in Adult-type Diffuse Glioma Lacking Contrast Enhancement. Kang KM; Song J; Choi Y; Park C; Park JE; Kim HS; Park SH; Park CK; Choi SH Radiology; 2024 May; 311(2):e233120. PubMed ID: 38713025 [TBL] [Abstract][Full Text] [Related]
8. The T2-FLAIR-mismatch sign as an imaging biomarker for IDH and 1p/19q status in diffuse low-grade gliomas: a systematic review with a Bayesian approach to evaluation of diagnostic test performance. Goyal A; Yolcu YU; Goyal A; Kerezoudis P; Brown DA; Graffeo CS; Goncalves S; Burns TC; Parney IF Neurosurg Focus; 2019 Dec; 47(6):E13. PubMed ID: 31786548 [TBL] [Abstract][Full Text] [Related]
9. Re-evaluation of the diagnostic performance of Kim D; Chun JH; Kim SH; Moon JH; Kang SG; Chang JH; Yun M Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1678-1684. PubMed ID: 31102001 [TBL] [Abstract][Full Text] [Related]
10. Zhao K; Yu P; Xue Z; Liu J; Yao A; Zhao Y; Yang F; Tian J; Xu B Acad Radiol; 2020 Jul; 27(7):e159-e167. PubMed ID: 31607471 [TBL] [Abstract][Full Text] [Related]
12. Static and dynamic Verger A; Stoffels G; Bauer EK; Lohmann P; Blau T; Fink GR; Neumaier B; Shah NJ; Langen KJ; Galldiks N Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):443-451. PubMed ID: 29043400 [TBL] [Abstract][Full Text] [Related]
13. Multi-parametric Z-spectral MRI may have a good performance for glioma stratification in clinical patients. Su C; Xu S; Lin D; He H; Chen Z; Damen FC; Ke C; Lv X; Cai K Eur Radiol; 2022 Jan; 32(1):101-111. PubMed ID: 34272981 [TBL] [Abstract][Full Text] [Related]
14. Biological tumour volumes of gliomas in early and standard 20-40 min Unterrainer M; Winkelmann I; Suchorska B; Giese A; Wenter V; Kreth FW; Herms J; Bartenstein P; Tonn JC; Albert NL Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1242-1249. PubMed ID: 29487977 [TBL] [Abstract][Full Text] [Related]
15. Neuroimaging-Based Classification Algorithm for Predicting 1p/19q-Codeletion Status in Batchala PP; Muttikkal TJE; Donahue JH; Patrie JT; Schiff D; Fadul CE; Mrachek EK; Lopes MB; Jain R; Patel SH AJNR Am J Neuroradiol; 2019 Mar; 40(3):426-432. PubMed ID: 30705071 [TBL] [Abstract][Full Text] [Related]
17. Predicting 1p/19q codeletion status using diffusion-, susceptibility-, perfusion-weighted, and conventional MRI in IDH-mutant lower-grade gliomas. Yang X; Lin Y; Xing Z; She D; Su Y; Cao D Acta Radiol; 2021 Dec; 62(12):1657-1665. PubMed ID: 33222488 [TBL] [Abstract][Full Text] [Related]
18. Whole-Tumor Histogram and Texture Analyses of DTI for Evaluation of Park YW; Han K; Ahn SS; Choi YS; Chang JH; Kim SH; Kang SG; Kim EH; Lee SK AJNR Am J Neuroradiol; 2018 Apr; 39(4):693-698. PubMed ID: 29519794 [TBL] [Abstract][Full Text] [Related]
19. Prediction of Park YW; Han K; Ahn SS; Bae S; Choi YS; Chang JH; Kim SH; Kang SG; Lee SK AJNR Am J Neuroradiol; 2018 Jan; 39(1):37-42. PubMed ID: 29122763 [TBL] [Abstract][Full Text] [Related]
20. Alpha Internexin: A Surrogate Marker for 1p/19q Codeletion and Prognostic Marker in Anaplastic (WHO grade III) Gliomas. Rajmohan KS; Sugur HS; Shwetha SD; Pandey P; Arivazhagan A; Santosh V Neurol India; 2020; 68(4):832-837. PubMed ID: 32859823 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]